Crystal structure of NTPDase2 in complex with the sulfoanthraquinone inhibitor PSB-071

Journal of Structural Biology

Volumn 185, Issue 3, 2014, Pages 336-341

  Zebisch, Matthias ^a,b   Baqi, Younis ^c,d   Schäfer, Petra ^a,e   Müller, Christa E ^c   Sträter, Norbert ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BONN   (Germany)

^d SULTAN QABOOS UNIVERSITY   (Oman)

^e LEIBNIZ INSTITUTE OF PLANT BIOCHEMISTRY   (Germany)

Author keywords

Anthraquinone; Apyrase; CD39; Nucleotidase; Reactive blue 2; Structure based drug design

Indexed keywords

1 AMINO 4 (3 METHYLPHENYL)AMINO 9,10 DIOXO 9,10 DIHYDROANTHRACENE 2 SULFONATE; ANTHRAQUINONE DERIVATIVE; APYRASE; CD39 LIKE ECTO NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 2; CIBACRON BLUE F3GA; HYDROLASE INHIBITOR; NUCLEOSIDE; PSB 071; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; COMPLEX FORMATION; CRYSTAL STRUCTURE; DRUG BINDING SITE; DRUG PROTEIN BINDING; ENZYME ACTIVE SITE; ENZYME CONFORMATION; ENZYME REGULATION; ENZYME STRUCTURE; PRIORITY JOURNAL; PROTEIN DOMAIN;

VERTEBRATA;

ANTHRAQUINONE; APYRASE; CD39; NUCLEOTIDASE; REACTIVE BLUE 2; STRUCTURE-BASED DRUG DESIGN;

ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANTHRAQUINONES; TRIAZINES;

EID: 84894503251     PISSN: 10478477     EISSN: 10958657     Source Type: Journal    
DOI: 10.1016/j.jsb.2014.01.005     Document Type: Article

References (43)

1. Antonioli L., Pacher P., Vizi E.S., Hasko G. CD39 and CD73 in immunity and inflammation. Trends Mol. Med. 2013, 19:355-367.
2. Augusto E., Matos M., Sévigny J., El-Tayeb A., Bynoe M.S., Müller C.E., Cunha R.A., Chen J.F. Ecto-5'-nucleotidase (CD73)-mediated formation of adenosine is critical for the striatal adenosine A2A receptor functions. J. Neurosci. 2013, 33:11390-11399.
3. Baqi Y., Weyler S., Iqbal J., Zimmermann H., Müller C.E. Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases). Purinergic Signal. 2009, 5:91-106.
4. Bartel D.L., Sullivan S.L., Lavoie E.G., Sévigny J., Finger T.E. Nucleoside triphosphate diphosphohydrolase-2 is the ecto-ATPase of type I cells in taste buds. J. Comp. Neurol. 2006, 32:1743-1751.
5. Bastid J., Cottalorda-Regairaz A., Alberici G., Bonnefoy N., Eliaou J.F., Bensussan A. ENTPD1/CD39 is a promising therapeutic target in oncology. Oncogene 2013, 32:1743-1751.
6. Braun N., Sévigny J., Mishra S.K., Robson S.C., Barth S.W., Gerstberger R., Hammer K., Zimmermann H. Expression of the ecto-ATPase NTPDase2 in the germinal zones of the developing and adult rat brain. Eur. J. Neurosci. 2003, 17:1355-1364.
7. Brunschweiger A., Iqbal J., Umbach F., Scheiff A.B., Munkonda M.N., Sévigny J., Knowles A.F., Müller C.E. Selective nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) inhibitors: nucleotide mimetics derived from uridine-5'-carboxamide. J. Med. Chem. 2008, 51:4518-4528.
8. Feng L., Sun X., Csizmadia E., Han L., Bian S., Murakami T., Wang X., Robson S.C., Wu Y. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate. Neoplasia 2011, 13:206-216.
9. Iqbal J., Vollmayer P., Braun N., Zimmermann H., Müller C.E. A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) and the analysis of inhibitors by in-capillary enzymatic microreaction. Purinergic Signal. 2005, 1:349-358.
10. Ivanenkov V.V., Crawford P.A., Toyama A., Sévigny J., Kirley T.L. Epitope mapping in cell surface proteins by site-directed masking: defining the structural elements of NTPDase3 inhibition by a monoclonal antibody. Protein Eng. Des. Sel. 2010, 23:579-588.
11. Jin D., Fan J., Wang L., Thompson L.F., Liu A., Daniel B.J., Shin T., Curiel T.J., Zhang B. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Cancer Res. 2010, 70:2245-2255.
12. Kabsch W. XDS. Acta Crystallogr. D. Biol. Crystallogr. 2010, 66:125-132.
13. Kharasch E.D., Novak R.F. Spectroscopic evidence for anthracenedione antineoplastic agent self-association and complex formation with flavin nucleotides. Arch. Biochem. Biophys. 1984, 234:497-512.
14. Knapp K., Zebisch M., Pippel J., El-Tayeb A., Müller C.E., Sträter N. Crystal structure of the human ecto-5'-nucleotidase (CD73): insights into the regulation of purinergic signaling. Structure 2012, 20:2161-2173.
15. Knapp K.M., Zebisch M., Sträter N. Crystallization and preliminary X-ray analysis of the open form of human ecto-5'-nucleotidase (CD73). Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun. 2012, 68:1545-1549.
16. Krug U., Totzauer R., Sträter N. The crystal structure of Toxoplasma gondii nucleoside triphosphate diphosphohydrolase 1 represents a conformational intermediate in the reductive activation mechanism of the tetrameric enzyme. Proteins. 2013, 81:1271-1276.
17. Krug U., Totzauer R., Zebisch M., Sträter N. The ATP/ADP substrate specificity switch between Toxoplasma gondii NTPDases1 and -3 is caused by an altered substrate base binding mode. Chembiochem. 2013, 14:2292-2300.
18. Krug U., Zebisch M., Krauss M., Sträter N. Structural insight into activation mechanism of Toxoplasma gondii nucleoside triphosphate diphosphohydrolases by disulfide reduction. J. Biol. Chem. 2012, 287:3051-3066.
19. Mandapathil M., Hilldorfer B., Szczepanski M.J., Czystowska M., Szajnik M., Ren J., Lang S., Jackson E.K., Gorelik E., Whiteside T.L. Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells. J. Biol. Chem. 2010, 285:7176-7186.
20. Müller C.E., Iqbal J., Baqi Y., Zimmermann H., Rollich A., Stephan H. Polyoxometalates-a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors. Bioorg. Med. Chem. Lett. 2006, 16:5943-5947.
21. Piosik J., Zdunek M., Kapuscinski J. The modulation by xanthines of the DNA-damaging effect of polycyclic aromatic agents. Part II. The stacking complexes of caffeine with doxorubicin and mitoxantrone. Biochem. Pharmacol. 2002, 63:635-646.
22. Poornam G.P., Matsumoto A., Ishida H., Hayward S. A method for the analysis of domain movements in large biomolecular complexes. Proteins 2009, 76:201-212.
23. Sévigny J., Sundberg C., Braun N., Guckelberger O., Csizmadia E., Qawi I., Imai M., Zimmermann H., Robson S.C. Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. Blood 2002, 99:2801-2809.
24. Shukla V., Zimmermann H., Wang L., Kettenmann H., Raab S., Hammer K., Sevigny J., Robson S.C., Braun N. Functional expression of the ecto-ATPase NTPDase2 and of nucleotide receptors by neuronal progenitor cells in the adult murine hippocampus. J. Neurosci. Res. 2005, 80:600-610.
25. Stagg J. The double-edge sword effect of anti-CD73 cancer therapy. Oncoimmunology 2012, 1:217-218.
26. Stagg J., Divisekera U., Duret H., Sparwasser T., Teng M.W., Darcy P.K., Smyth M.J. CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis. Cancer Res. 2011, 71:2892-2900.
27. Stagg J., Divisekera U., McLaughlin N., Sharkey J., Pommey S., Denoyer D., Dwyer K.M., Smyth M.J. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc. Natl. Acad. Sci. USA 2010, 107:1547-1552.
28. Stagg J., Smyth M.J. Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 2010, 29:5346-5358.
29. Stephan H., Kubeil M., Emmerling F., Müller C.E. Polyoxometalates as versatile enzyme inhibitors. Eur. J. Inorg. Chem. 2013, 2013:1585-1594.
30. Stornaiuolo M., De Kloe G.E., Rucktooa P., Fish A., van E.R., Edink E.S., Bertrand D., Smit A.B., de E.I., Sixma T.K. Assembly of a pi-pi stack of ligands in the binding site of an acetylcholine-binding protein. Nat. Commun. 2013, 4:1875.
31. Vandenbeuch A., Anderson C.B., Parnes J., Enjyoji K., Robson S.C., Finger T.E., Kinnamon S.C. Role of the ectonucleotidase NTPDase2 in taste bud function. Proc. Natl. Acad. Sci. USA 2013, 110:14789-14794.
32. Vivian J.P., Riedmaier P., Ge H., Le N.J., Sansom F.M., Wilce M.C., Byres E., Dias M., Schmidberger J.W., Cowan P.J., et al. Crystal structure of a Legionella pneumophila ecto -triphosphate diphosphohydrolase, a structural and functional homolog of the eukaryotic NTPDases. Structure 2010, 18:228-238.
33. Wang L., Tang S., Wang Y., Xu S., Yu J., Zhi X., Ou Z., Yang J., Zhou P., Shao Z. Ecto-5'-nucleotidase (CD73) promotes tumor angiogenesis. Clin. Exp. Metastasis 2013, 30:671-680.
34. Winn M.D., Ballard C.C., Cowtan K.D., Dodson E.J., Emsley P., Evans P.R., Keegan R.M., Krissinel E.B., Leslie A.G., McCoy A., et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D. Biol. Crystallogr. 2011, 67:235-242.
35. Zebisch M., Krauss M., Schäfer P., Lauble P., Sträter N. Crystallographic snapshots along the reaction pathway of nucleoside triphosphate diphosphohydrolases. Structure 2013, 21:1460-1475.
36. Zebisch M., Krauss M., Schäfer P., Sträter N. Crystallographic evidence for a domain motion in rat nucleoside triphosphate diphosphohydrolase (NTPDase) 1. J. Mol. Biol. 2012, 415:288-306.
37. Zebisch, M., Krauss, M., Schäfer, P., Sträter, N. 2014. Legionella pneumophila NTPDase1 in complex with polyoxometallates. Acta Crystallogr. D. Biol. Crystallogr. in press.
38. Zebisch M., Schäfer P., Lauble P., Sträter N. New crystal forms of NTPDase1 from the bacterium Legionella pneumophila. Acta Crystallogr. Sect. F. 2013, 69:257-262.
39. Zebisch M., Sträter N. Characterization of Rat NTPDase1, -2, and -3 ectodomains refolded from bacterial inclusion bodies. Biochemistry 2007, 46:11945-11956.
40. Zebisch M., Sträter N. Structural insight into signal conversion and inactivation by NTPDase2 in purinergic signaling. Proc. Natl. Acad. Sci. USA 2008, 105:6882-6887.
41. Zhang B. CD73 promotes tumor growth and metastasis. Oncoimmunology 2012, 1:67-70.
42. Zimmermann H. Purinergic signaling in neural development. Semin. Cell Dev. Biol. 2011, 22:194-204.
43. Zimmermann H., Zebisch M., Sträter N. Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal. 2012, 8:437-502.